President Biden has capped insulin at $35 for seniors, ensuring Americans don't have to choose between life-saving medication and basic necessities. This measure, part of the Inflation Reduction Act passed in 2022, is saving some Medicare beneficiaries hundreds of dollars a month. Starting in 2025, yearly Part D out-of-pocket costs will be capped at $2,000. Efforts are underway in Congress, led by Rep. Joe Courtney, to expand these savings to working-age Americans. Additionally, the Prescription Drug Price Relief Act, introduced by Rep. Ro Khanna and Sen. Bernie Sanders, aims to lower prescription drug prices and hold the pharmaceutical industry accountable.
Access to insulin is life or death. That's why I supported the Inflation Reduction Act, to cap the cost of insulin at $35 for Medicare recipients. Now, Democrats are working to cap insulin costs for ALL Americans.
Americans shouldn’t pay a dime more for prescription drugs than people in other countries. My bill with @SenSanders, the Prescription Drug Price Relief Act, will lower prices and hold the pharmaceutical industry accountable for ripping off American patients.
Because Congress passed the Inflation Reduction Act in 2022, the cost of insulin is now capped at $35/month for Medicare beneficiaries. This is saving some seniors hundreds of dollars a month, and I’m working in Congress to expand these savings to working age Americans too.
Thanks to the Inflation Reduction Act, #Medicare drug price negotiations are helping lower prescription costs. Starting in 2025, yearly Part D out-of-pocket costs will be capped at $2,000. Learn more about upcoming prescription savings at https://t.co/biTK6pf9U3. https://t.co/XSGrbU7CoZ
People shouldn’t have to choose between life-saving medication and food and shelter. President Biden has capped insulin at $35 for seniors so that Americans don’t have to make that choice. It's not just about lowering costs — it's about saving lives.